BC
About
BroadOak Capital Partners is a Washington DC and San Francisco-based boutique financial institution focused on the life sciences sector. Founded in 2006, the firm provides direct growth-stage investment and investment banking services to companies in research tools and consumables, diagnostics, biopharma services, cell and gene therapy, single-cell genomics, and life sciences software.
Sector Focus
Life Sciences
Diagnostics
Biopharma
Healthcare Tools
Gene Therapy
Series Focus
Series A
Series B
Growth
Portfolio
Investment Activity
No timeline data for this period
Score Breakdown
17Deal Activity
0Track Record
0Visibility
0Profile
85Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is BroadOak Capital Partners?
BroadOak Capital Partners is a Washington DC and San Francisco-based boutique financial institution focused on the life sciences sector. Founded in 2006, the firm provides direct growth-stage investment and investment banking services to companies in research tools and consumables, diagnostics, biopharma services, cell and gene therapy, single-cell genomics, and life sciences software.
What kind of firm is BroadOak Capital Partners?
BroadOak Capital Partners is a venture_capital.
Where is BroadOak Capital Partners based?
BroadOak Capital Partners is based in United States.
What sectors does BroadOak Capital Partners focus on?
BroadOak Capital Partners focuses on Life Sciences, Diagnostics, Biopharma, Healthcare Tools.
Similar Investors